Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
DGTI 2023
Programm
Personen
Suche
EN
Alle Personen
Prof. Dr. Hubert Schrezenmeier
Ulm/ DE
DRK-Blutspendedienst Baden-Württemberg | Hessen
Sortiert nach Typ
Datum
Vorsitz
22.09.2023
10:30
–
12:00
Plenarsitzung
Blood Safety
MOA 04+05
eingeladene Redner
20.09.2023
14:45
–
15:00
15 Min.
0 Min.
Vortrag
VS-7-2
Leitlinien supportive Therapie: Anämie
Weitere Beteiligungen
21.09.2023
16:38
–
16:42
3 Min.
1 Min.
ePoster
PS-5-4
Antibodies inhibiting cell-to-cell spread of herpes simplex virus type 1 protect against viral reactivations: a retrospective study
Immunotherapy
21.09.2023
16:40
–
16:45
3 Min.
2 Min.
ePoster
PS-3-3
SARS-CoV2 mRNA vaccine-specific B-, T-, humoral responses in pediatric stem cell transplant recipients – Importance of a booster vaccination
COVID-19
21.09.2023
16:42
–
16:44
2 Min.
0 Min.
ePoster
PS-4-7
Characteristics of red cell transfusion dependent outpatients: a single center experience
Hemotherapy
21.09.2023
16:45
–
16:50
3 Min.
2 Min.
ePoster
PS-3-4
Validation of a modified rapid antibody test to identify COVID-19 patients with low neutralizing antibody titers in an outpatient setting
COVID-19
21.09.2023
16:46
–
16:50
3 Min.
1 Min.
ePoster
PS-5-7
Unstimulated autologous and allogenic mononuclear cell apheresis
Immunotherapy
21.09.2023
16:50
–
16:55
3 Min.
2 Min.
ePoster
PS-1-6
Application of Far-UVC for disinfection of corneal tissue
Biobanking and Tissue Banking
21.09.2023
17:06
–
17:10
3 Min.
1 Min.
ePoster
PS-5-15
Ten years of manufacturing MSC at the IKT Ulm – perspectives for autologous MSC therapies?
Stem Cells
21.09.2023
17:10
–
17:15
3 Min.
2 Min.
ePoster
PS-3-9
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
COVID-19
21.09.2023
17:14
–
17:18
3 Min.
1 Min.
ePoster
PS-5-17
Effect of expansion media on functional characteristics of bone marrow-derived mesenchymal stromal cells
Stem Cells
21.09.2023
17:15
–
17:20
3 Min.
2 Min.
ePoster
PS-3-10
A randomised open-label trial of early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 as model of early treatment in a pandemia with a new pathogen: Experience from collection of very high-titer plasma from superimmunized individuals
COVID-19
21.09.2023
17:20
–
17:25
3 Min.
2 Min.
ePoster
PS-3-11
Effective neutralizing and cellular immunity against SARS-CoV-2 after mRNA booster vaccination is associated with the activation of B cells and pDCs
COVID-19
21.09.2023
17:26
–
17:28
2 Min.
0 Min.
ePoster
PS-4-29
Case report: Anti-U caused mild haemolytic disease of the newborn
Immunohematology
21.09.2023
17:26
–
17:30
3 Min.
1 Min.
ePoster
PS-5-21
Dynamics in Apheresis of human hematopoietic Progenitor Cells
Stem Cells
21.09.2023
17:30
–
17:34
3 Min.
1 Min.
ePoster
PS-5-22
Improvements in unrelated donor search for hematopoietic stem cell transplantation over the last 10 years –Experience of the search unit Ulm
Stem Cells
21.09.2023
17:51
–
17:54
2 Min.
1 Min.
ePoster
PS-2-28
Platelet-activating factor promotes activation of neutrophil granulocytes in conjunction with the formation of platelet-neutrophil complexes
Hemostaseology
22.09.2023
08:30
–
08:45
12 Min.
3 Min.
Freier Vortrag
VS-21-1
Outcomes of haploidentical stem cell transplantation with post-tx-cyclophosphamide in comparison with 10/10 MUD in Germany - An observational analysis of German registry data
Stem Cells
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz